THBS1 and colorectal carcinoma: Several reports have demonstrated elevated levels of THBS1 in other treatment-resistant cancers35–38, suggesting that our findings in CRC may be applicable to a broad spectrum of malignancies with mesenchyme-/stroma-active characteristics.